Clinical trial · Interventional
Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes
A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes
NCT00805597CI-TRIAL-00023396terminatedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): The recuiting was to slow to complete the study
Summary
Brief summary (as posted)
The purpose of this study is to evaluate postmastectomy radiotherapy in breast cancer patients with one to three positive nodes.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| no radiation | Radiation | — | UNRESOLVED |
| radiation | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- radiotherapy
- description
- radiotherapy of 50Gy/25/f/5w to the ipsilateral chest wall and supraclavicular region
- interventionNames
- Radiation: radiation
- type
- ACTIVE_COMPARATOR
- label
- no radiotherapy
- description
- no radiotherapy
- interventionNames
- Radiation: no radiation
Primary outcomes (1)
- measure
- overall survival
- timeFrame
- 10 years
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Ipsilateral histologically confirmed invasive breast cancer * Undergone total mastectomy and axillary dissection * T1-2 and one to three axillary lymph nodes positive * A minimum of 10 axillary nodes dissected * Fit for chemotherapy(if indicated),endocrine therapy(if indicated)and postoperative irradiation * Written,informed consent Exclusion Criteria: * Patients who undergone previous irradiation to the ipsilateral chest wall and supraclavicular region * Previous or concurrent malignant other than non-melanomatous skin cancer * Unable or unwilling to give informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.